In addition to the therapeutic potential of IL23p40 in autoimmune diseases, as demonstrated in our study, targeting a functional IL23R-CHR in IL23 receptor complex could also provide a useful route for ameliorating IL23/IL17-involved inflammatory diseases. Here, IL17A is linked to autoimmune disease.